Genewell
Latest round
- Series B
Last raised
- Aug 2026
Total raised
- Undisclosed
Investors
- 5
About Genewell
, trading as Genewell, operates as a molecular diagnostic standards developer that provides in vitro molecular diagnostic tests and related products. Genewell has about 100 employees and many of the core team members come from Cambridge University, Fudan University and the Chinese Academy of Sciences. The company's products divided into tumor, pathogenic microorganism and customized products. Tumor includes pan - tumor 800 gDNA, lung cancer and colorectal cancer gDNA, ctDNA and FFPE. And pan - tumor covers more than 330 genes and more than 720 mutations. Customized products include HRR QC, viral nucleic acid QC, macro genome sequencing QC and HPV nucleic acid detection QC. The company also provides customized service - gene editing service. The company's revenue is generated by providing gene testing services.
Who invested in Genewell
5 investors across 3 rounds
See all investors in Genewell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genewell
Who invested in Genewell?
Genewell has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genewell raised?
Genewell has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Genewell last raise money?
Genewell's most recent round on record is a Series B, in Aug 2026.
What does Genewell do?
, trading as Genewell, operates as a molecular diagnostic standards developer that provides in vitro molecular diagnostic tests and related products.
Where is Genewell headquartered?
Genewell is headquartered in Shenzhen, China.
Which VCs invest in companies like Genewell?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Genewell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Genewell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.